UCHL-1 is not a Parkinson's disease susceptibility gene

被引:89
作者
Healy, DG
Abou-Sleiman, PM
Casas, JP
Ahmadi, KR
Lynch, T
Gandhi, S
Muqit, MMK
Foltynie, T
Barker, R
Bhatia, KP
Quinn, NP
Lees, AJ
Gibson, JM
Holton, JL
Revesz, T
Goldstein, DB
Wood, NW
机构
[1] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[2] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England
[3] UCL, Dept Biol, London, England
[4] Mater Misericordiae Univ Hosp, Dept Neurol, Dublin, Ireland
[5] Univ Cambridge, Cambriudge Ctr Brain Repair, Cambridge CB2 1TN, England
[6] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England
[7] Univ London, Reta Lila Weston Inst Neurol Studies, London, England
[8] Belfast City Hosp, Dept Neurol, Belfast BT9 7AD, Antrim, North Ireland
基金
英国医学研究理事会;
关键词
D O I
10.1002/ana.20757
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The UCHL-1 gene is widely cited as a susceptibility factor for sporadic Parkinson's disease (PD). The strongest evidence comes from a meta-analysis of small studies that reported the S18Y polymorphism as protective against PD, after pooling studies of white and Asian subjects. Here, we present data that challenge this association. Methods. In a new large case-control study in white individuals (3,023 subjects), the S18Y variant was not protective against PD under any genetic model of inheritance. Similarly, a more powerful haplotype-tagging approach did not detect other associated variants. Results: Finally, in an updated S18Y-PD meta-analysis (6,594 subjects), no significant association was observed under additive, recessive, or dominant models (odds ratio 1.00 [95% confidence interval: 0.74-1.33]; odds ratio = 1.01 [95% confidence interval: 0.76-1.35]; and odds ratio 0.96 [95% confidence interval: 0.86-1.08), respectively), and a cumulative meta-analysis showed a trend toward a null effect. Interpretation Based on the current evidence, the UCHL-1 gene does not exhibit a protective effect in PD.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 28 条
  • [1] Parameters for reliable results in genetic association studies in common disease
    Dahlman, I
    Eaves, IA
    Kosoy, R
    Morrison, VA
    Heward, J
    Gough, SCL
    Allahabadia, A
    Franklyn, JA
    Tuomilehto, J
    Tuomilehto-Wolf, E
    Cucca, F
    Guja, C
    Ionescu-Tirgoviste, C
    Stevens, H
    Carr, P
    Nutland, S
    McKinney, P
    Shield, JP
    Wang, W
    Cordell, HJ
    Walker, N
    Todd, JA
    Concannon, P
    [J]. NATURE GENETICS, 2002, 30 (02) : 149 - 150
  • [2] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [3] S18Y polymorphism in the UCH-L1 gene and Parkinson's disease:: Evidence for an age-dependent relationship
    Elbaz, A
    Levecque, C
    Clavel, J
    Vidal, JS
    Richard, F
    Corrèze, JR
    Delemotte, B
    Amouyel, P
    Alpérovitch, A
    Chartier-Harlin, MC
    Tzourio, C
    [J]. MOVEMENT DISORDERS, 2003, 18 (02) : 130 - 137
  • [4] GASSER T, 2000, MOVEMENT DISORD, V15, pA201
  • [5] THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE
    GIBB, WRG
    LEES, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) : 745 - 752
  • [6] Genome scans and candidate gene approaches in the study of common diseases and variable drug responses
    Goldstein, DB
    Ahmadi, KR
    Weale, ME
    Wood, NW
    [J]. TRENDS IN GENETICS, 2003, 19 (11) : 615 - 622
  • [7] The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism
    Healy, DG
    Abou-Sleiman, PM
    Ahmadi, KR
    Muqit, MMK
    Bhatia, KP
    Quinn, NP
    Lees, AJ
    Latchmann, DS
    Goldstein, DB
    Wood, NW
    [J]. ANNALS OF NEUROLOGY, 2004, 56 (03) : 329 - 335
  • [8] ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES
    HUGHES, AJ
    DANIEL, SE
    KILFORD, L
    LEES, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) : 181 - 184
  • [9] Replication validity of genetic association studies
    Ioannidis, JPA
    Ntzani, EE
    Trikalinos, TA
    Contopoulos-Ioannidis, DG
    [J]. NATURE GENETICS, 2001, 29 (03) : 306 - 309
  • [10] The ubiquitin pathway in Parkinson's disease
    Leroy, E
    Boyer, R
    Auburger, G
    Leube, B
    Ulm, G
    Mezey, E
    Harta, G
    Brownstein, MJ
    Jonnalagada, S
    Chernova, T
    Dehejia, A
    Lavedan, C
    Gasser, T
    Steinbach, PJ
    Wilkinson, KD
    Polymeropoulos, MH
    [J]. NATURE, 1998, 395 (6701) : 451 - 452